XML 82 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2021
Aug. 26, 2021
Jan. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 09, 2021
May 15, 2020
Jan. 01, 2016
Shareholders' Equity (Details) [Line Items]                    
Purchase Of Aggregate Shares   3,703,704                
Offering price per shares (in Dollars per share)   $ 0.54                
Aggregate purchase price   1,851,852                
Common share percentage   50.00%                
Exercise price (in Dollars per share)   $ 0.65                
Warrant to purchase price   269,269                
Number Of common share in percentage   8.00%                
Offering price per share (in Dollars per share)   $ 0.675                
Offering price per share   125.00%                
Exercise price payable (in Dollars)   $ 1,719,921                
Sales of stock, shares 3,703,704   1,038,500              
Exercise price (in Dollars per share) $ 0.65                  
Issued common stock to consultant           677,242 1,214,861      
Aggregate grant date fair value of warrants issued (in Dollars)           $ 39,632      
Warrants shares exercised                 153,625  
Issuance of common stock               20,000,000    
Shares issued to employee           1,235,047 724,992      
Shares issued to employee           428,543 724,992      
Stock options exercised (in Dollars)           $ 16,450        
Stock options exercised           145,500      
Employee Equity Incentive Plan [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Stock based compensation recognized for grants (in Dollars)       $ 60,422 $ 79,196 $ 239,729 $ 109,349      
Unrecognized stock compensation (in Dollars)       25,575   25,575        
Share-based Payment Arrangement, Option [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Stock based compensation recognized for grants (in Dollars)       9,615 $ 19,305 64,304 61,155      
Consultant [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Recognized expenses (in Dollars)           $ 151,322 $ 156,501      
Director [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Issued common stock to consultant           806,504        
Stock Issued During Period of shares             During the nine months ended September 30, 2021 and 2020, the Company issued 1,235,047 and 724,992 shares under the 2016 EIP pursuant to the grants and vesting described in the tables above, respectively, of which 428,543 and 724,992, respectively were issued to employees and 806,504 and -0-, respectively, were issued to directors.        
Three Separate Private Placement [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Sales of stock, shares           13,161,943 6,650,843      
Proceeds from sale (in Dollars)       $ 4,328,725   $ 4,328,725        
Proceeds from sale of stock (in Dollars)             $ 673,001      
Minimum [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Stock option exercise price (in Dollars per share)           $ 0.1        
Maximum [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Stock option exercise price (in Dollars per share)           $ 0.252        
Employee Equity Incentive Plan [Member] | Common Stock [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Common shares, issued                   15,503,680
Investment Agreement [Member] | Common Stock [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Common shares, issued       3,006,098 4,975,491 3,006,098 4,975,491      
Net proceeds (in Dollars)           $ 900,636 $ 426,299      
Warrant One [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Warrants to purchase shares of common stock             0.27      
Warrant One [Member] | Three Separate Private Placement [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Warrants to purchase shares of common stock           6,581,527 3,463,825      
Exercise price (in Dollars per share)       $ 1.05 $ 0.16 $ 1.05 $ 0.16      
Three-year warrants [Member] | Three Separate Private Placement [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Exercise price (in Dollars per share)       $ 0.27   $ 0.27        
Warrant [Member]                    
Shareholders' Equity (Details) [Line Items]                    
Issued warrants           22,421,026 3,463,825      
Aggregate grant date fair value of warrants issued (in Dollars)           $ 5,823,476 $ 222,987      
Issued common shares upon exercise       333,750   333,750        
Warrants shares exercised       3,065,278   3,065,278        
Exercise price (in Dollars per share)           $ 0.09 $ 0.15      
Cashless exercise       9,047,332   9,047,332        
Warrant shares exercised         10,571,742   10,571,742      
Litigation and other disputes amounts (in Dollars)             $ 614,221